Results Group, The, L.L.C., et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
062 3205
Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Displaying 301 - 320 of 447
Verity International, Ltd., et al.,Defendants
Type of Action
Federal
Last Updated
FTC Matter/File Number
002-3386
Actavis Group hf. and Abrika Pharmaceuticals, Inc., In the Matter of
The Commission prevented a merger-to-monopoly in the sale of generic isradipine capsules by challenging the proposed $235 million purchase of Abrika Pharmaceuticals, Inc., by the Actavis Group, an international generic pharmaceuticals company. To maintain competition in the market for this important generic drug, used to lower blood pressure and to treat hypertension, ischemia, and depression, the consent order requires the divestiture of all rights and assets necessary to produce, market, and sell generic isradipine to Cobalt Laboratories, Inc.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0710063
Hospira, Inc., and Mayne Pharma Limited, In the Matter of
The consent order settles charges that Hospira Inc.’s proposed $2 billion acquisition of rival drug manufacturer Mayne Pharma Ltd. would likely reduce competition in the following products: hydromorphone hydrochloride (hydromorphone), nalbuphine hydrochloride (nalbuphine), morphine sulfate (morphine), preservative-free morphine, and deferoxamine mesylate (deferoxamine). In settling the Commission’s charges, the companies agreed to divest to Barr Pharmaceuticals, Inc. (Barr), within 10 days of the acquisition, Mayne’s rights and assets related to the relevant products.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0710002
Docket Number
C-4182
TC Group, LLC., Riverstone Holdings LLC, Carlyle/Riverstone Global Energy and Power Fund II, LP, and Carlyle/Riverstone Global Energy and Power Fund III, LP, In the Matter of
The order settles charges that the proposed $22 billion deal whereby energy transportation, storage, and distribution firm Kinder Morgan, Inc. (KMI) would be taken private by KMI management and a group of investment firms, including private equity funds managed and controlled by The Carlyle Group (Carlyle) and Riverstone Holdings LLC (Riverstone) would threaten competition between KMI and Magellan in eleven metropolitan areas in the Southeast, likely resulting in higher prices for gasoline and other light petroleum products. The order requires that Carlyle’s and Riverstone’s interest in Magellan become a passive investment, by requiring them to: (1) removing all of their representatives from the Magellan Board of Managers and its boards of directors, (2) ceding control of Magellan to its other principal investor, Madison Dearborn Partners, and (3) not influencing or attempting to influence the management or operation of Magellan.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610197
Docket Number
C-4183
Internet Marketing Group, Inc., a Tennessee Corporation; et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
042-3035
National Vending Consultants, Inc., Success Vending Group, Inc., USA Candy Express, Inc.,et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
X000039
627867 B.C. LTD. d/b/a Newport Group, et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
032 3100
X04 0004
Alon Israel Oil Company Ltd./Apex Oil Company, Inc. (Edgington Oil Company)
Date
Matter Number
061 0224
Sagee U.S.A. Group, Inc., et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
032-3140
Fresenius AG, In the Matter of
Fresenius AG settled charges that its purchase of rival dialysis provider Renal Care Group, Inc. would likely have resulted in higher prices for dialysis services. The consent order requires that Fresenius AG will sell 91 outpatient kidney dialysis clinics and financial interests in 12 more.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
051 0154
Docket Number
C-4159
Dynamic Health Of Florida, LLC; Chhabra Group, LLC, et al., In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
042 3002
Docket Number
9317
Allergan, Inc., and Inamed Corporation, In the Matter of
The consent order requires that Allergan and Inamed divest the rights to develop and distribute Reloxin, a potential Botox rival, to settle charges that Allergan’s $3.2 billion purchase of Inamed would reduce competition and force consumers to pay higher prices for botulinum toxin type A products. Under the terms of the FTC settlement, the companies will return the development and distribution rights to Reloxin to Ipsen Ltd., its U.K.- based manufacturer.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
061 0031
Docket Number
C-4156
Teva Pharmaceutical Industries Ltd. and IVAX Corporation, In the Matter of
The consent order allowed Teva to acquire IVAX Corporation, provided the companies sell the rights and assets needed to manufacture and market 15 generic pharmaceutical products. Among the drugs sold were several forms of generic amoxicillin and amoxicillin clavulanate potassium that are widely used in the United States.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
051 0214
Docket Number
C-4155
Displaying 301 - 320 of 447